Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine Prophylaxis for COVID-19 in Healthcare Workers
NCT04627467Phase 2Completed
- Sponsor
- Fundación Valle del Lili
- Start
- Mar 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of chloroquine in coronavirus disease 2019 (COVID-19), sponsored by Fundación Valle del Lili. Primary endpoint: Incidence of COVID-19 Infection at Day 90. Started Mar 2020; status: completed.
02
Drugs
chloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04627467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04627467.